Tools
Tools
Farr, Katherine, Ravindran, Resmi, Strnad, Luke, Chang, Emily, Chaisson,, Lelia H, Yoon, Christina, Worodria, William, Andama, Alfred, Ayakaka, Irene 
ORCID: https://orcid.org/0000-0003-1051-5684, Nalwanga, Priscilla Bbosa, Byanyima, Patrick, Kalema, Nelson, Kaswabuli, Sylvia, Katagira, Winceslaus, Aman, Kyomugisha Denise, Tumwine,, Nuwagaba Wallen, Sanyu, Ingvar, Ssebunya, Robert, Davis, J. Lucian, Huang, Laurence, Khan, Imran H and Cattamanchi, Adithya
(2018)
'Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV'. PLoS ONE, Vol 13, Issue 10, e0206119.
|
Text (Research Article)
IA - journal.pone.0206119.pdf - Published Version Available under License Creative Commons Attribution. Download (634kB) | Preview |
Abstract
Background
Approaches to screening for active tuberculosis (TB) among people living with HIV are inadequate, leading to missed diagnoses and poor implementation of preventive therapy.
Methods
Consecutive HIV-infected adults hospitalized at Mulago Hospital (Kampala, Uganda) between June 2011 and July 2013 with a cough ≥ 2 weeks were enrolled. Patients underwent extensive evaluation for pulmonary TB. Concentrations of 43 cytokines/chemokines were measured at the same time point as C-reactive protein (CRP) in banked plasma samples using commercially-available multiplex kits. Advanced classification algorithms were used to rank cytokines/chemokines for their ability to identify TB, and to model the specificity of the top-ranked cytokines/chemokines individually and in combination with sensitivity constrained to ≥ 90% as recommended for TB screening.
Results
The median plasma level of 5 biomarkers (IL-6, INF-γ, MIG, CRP, IL-18) was significantly different between patients with and without TB. With sensitivity constrained to 90%, all had low specificity with IL-6 showing the highest specificity (44%; 95% CI 37.4–49.5). Biomarker panels were found to be more valuable than any biomarker alone. A panel combining IFN-γ and IL-6 had the highest specificity (50%; 95% CI 46.7–53.3). Sensitivity remained high (>85%) for all panels among sputum smear-negative TB patients.
Conclusions
Direct measurement of unstimulated plasma cytokines/chemokines in peripheral blood is a promising approach to TB screening. Cytokine/chemokine panels retained high sensitivity for smear-negative TB and achieved improved specificity compared to individual cytokines/chemokines. These markers should be further evaluated in outpatient settings where most TB screening occurs and where other illnesses associated with systematic inflammation are less common.
| Item Type: | Article |
|---|---|
| Subjects: | WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503 Acquired immunodeficiency syndrome. HIV infections WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503.1 Diagnosis WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503.6 Prevention and control WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General) |
| Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department |
| Digital Object Identifer (DOI): | https://doi.org/10.1371/journal.pone.0206119 |
| Depositing User: | Stacy Murtagh |
| Date Deposited: | 25 Oct 2018 16:29 |
| Last Modified: | 07 Nov 2018 09:07 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/9508 |
Statistics
Actions (login required)
 |
Edit Item |